Cargando…

Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases

SIMPLE SUMMARY: Approximately 20% of patients with cancer develop brain metastases (BM). Early BM diagnosis is critical to enable less invasive or toxic approaches. Sensitive and easy-to-use blood-based BM biomarkers may allow early diagnosis and appropriate timely treatment and may improve overall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Su-Hyun, Gwak, Ho-Shin, Lee, Youngjoo, Park, Na-Young, Han, Mira, Kim, Yeseul, Kim, So-Yeon, Kim, Ho Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125258/ https://www.ncbi.nlm.nih.gov/pubmed/34066445 http://dx.doi.org/10.3390/cancers13092227

Ejemplares similares

Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria
por: Lotz-Havla, Amelie S., et al.
Publicado: (2022)

Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy
por: Beerepoot, Shanice, et al.
Publicado: (2021)

Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas
por: Hepner, Adriana, et al.
Publicado: (2019)

Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL
por: Chen, Chih-Hao, et al.
Publicado: (2020)

Investigating the Presence of Interattack Astrocyte Damage in Neuromyelitis Optica Spectrum Disorder: Longitudinal Analysis of Serum Glial Fibrillary Acidic Protein
por: Hyun, Jae-Won, et al.
Publicado: (2021)

Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer’s disease
por: Parvizi, Tandis, et al.
Publicado: (2022)

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2021)

Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2023)

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study
por: Simone, Marta, et al.
Publicado: (2023)

Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke
por: Barba, Lorenzo, et al.
Publicado: (2023)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
por: Kessler, Christoph, et al.
Publicado: (2022)

Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury
por: Stukas, Sophie, et al.
Publicado: (2023)

Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder
por: Zhang, Tian-Xiang, et al.
Publicado: (2021)

Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury
por: Laverse, Etienne, et al.
Publicado: (2020)

Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients
por: Welford, Richard W.D., et al.
Publicado: (2022)

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
por: Vågberg, Mattias, et al.
Publicado: (2015)

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
por: Sjölin, Karl, et al.
Publicado: (2022)

Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury
por: Flynn, Spencer, et al.
Publicado: (2021)

Serum neurofilament light chain levels are correlated with the infarct volume in patients with acute ischemic stroke
por: Ahn, June Woo, et al.
Publicado: (2022)

Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
por: Yadav, Nidhi, et al.
Publicado: (2022)

Neurofilament Light Chain as A Biomarker for Brain Metastases
por: Winther-Larsen, Anne, et al.
Publicado: (2020)

A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias
por: Bolsewig, Katharina, et al.
Publicado: (2022)

Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2020)

Serum neurofilament light chain level as a predictor of cognitive stage transition
por: Lee, Eun-Hye, et al.
Publicado: (2022)

Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity
por: Bose, Gauruv, et al.
Publicado: (2023)

Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs
por: Yun, Taesik, et al.
Publicado: (2021)

Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
por: Kim, Su-Hyun, et al.
Publicado: (2022)

Serum neurofilament light chain as a severity marker for spinocerebellar ataxia
por: Shin, Hye-Rim, et al.
Publicado: (2021)

Differential patterns of nestin and glial fibrillary acidic protein expression in mouse hippocampus during postnatal development
por: Kim, Joong-Sun, et al.
Publicado: (2011)

Corrigendum: Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
por: Kim, Su-Hyun, et al.
Publicado: (2023)

Serum neurofilament light chain is increased in hereditary spastic paraplegias
por: Wilke, Carlo, et al.
Publicado: (2018)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
por: Hayashi, Tomohiro, et al.
Publicado: (2021)

Enhancing the clinical value of serum neurofilament light chain measurement
por: Kosa, Peter, et al.
Publicado: (2022)

Increased levels of neurofilament light chain in suicide attempters’ serum
por: Ramezani, Mahtab, et al.
Publicado: (2022)

Serum neurofilament light chain measurements following nerve trauma
por: Wilcox, Matthew, et al.
Publicado: (2023)

Modelling and Characterization of Glial Fibrillary Acidic Protein
por: Deka, Hemchandra, et al.
Publicado: (2015)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_60gu4fdeh7b0mi5klk21jgrp1j